SS&C TechnologiesGuidewire

SS&C Technologies vs Guidewire

SS&C Technologies vs Guidewire: this page compares business models, financial performance, and market context to help readers understand how the two companies operate. The presentation remains neutral...

Why It's Moving

SS&C Technologies

SS&C Technologies Attracts Wall Street Optimism With Record 2025 Results and Strong 2026 Guidance

  • Q4 2025 adjusted revenue reached $1,654.6 million with adjusted EPS of $1.69, demonstrating operational momentum that analysts view as evidence of the company's ability to execute in a competitive software and services landscape
  • Full-year 2026 revenue guidance of $6,654–$6,814 million signals management confidence in sustained growth, while the company generated $1,744.8 million in operating cash flow during 2025 and deployed over $1 billion toward share repurchases, returning capital to shareholders
  • Consensus earnings estimate revisions have moved higher over the recent month with four upward revisions and no downgrades, reflecting analyst confidence in the company's near-term earnings trajectory and contributing to its Zacks Rank #2 (Buy) designation
Sentiment:
🐃Bullish

Investment Analysis

Pros

  • SS&C Technologies demonstrated strong Q3 2025 results with 7% revenue growth and 17% earnings per share growth, reflecting solid operational execution.
  • The company has a diversified technology stack serving financial services and healthcare sectors, reducing dependency on any single market segment.
  • Analyst consensus rates SS&C as a strong buy with a forward price target indicating potential upside from current levels.

Considerations

  • SS&C's stock exhibits moderate volatility with a Beta of 1.23, indicating higher sensitivity to market swings compared to the broader market.
  • While the company pays a dividend, the yield is relatively low at around 1.28%, limiting income appeal to dividend-focused investors.
  • Recent short interest increased to over 30%, suggesting elevated bearish sentiment or hedging activity among some investors.

Pros

  • Guidewire Software benefits from a strong position in the insurance software market, supporting recurring revenue streams from its software platform.
  • The company’s growth prospects are driven by ongoing digital transformation trends and demand for cloud-based insurance solutions.
  • Guidewire maintains a dedicated R&D focus, enhancing product innovation and long-term competitive advantage in a niche market.

Considerations

  • Guidewire is currently considered significantly overvalued by analysts, trading at a large premium compared to intrinsic value estimates.
  • The company faces execution risks linked to transitioning customers to cloud models, which can impact near-term margins and growth visibility.
  • Macroeconomic uncertainty and competition from larger software vendors increasing pressure on pricing and customer acquisition.

Related Market Insights

Healthcare's Efficiency Crisis: Why Cost-Cutting Stocks Could Surge

Discover why UnitedHealth's cost-cutting signals a surge in healthcare efficiency stocks. Invest in AI & tech solutions driving industry savings.

Author avatar

Aimee Silverwood | Financial Analyst

July 30, 2025

Read Insight

The Unbreakable Bonds: Why These Companies Have Their Customers Trapped

Discover companies with high switching costs, ensuring predictable revenue & pricing power. Invest in indispensable market leaders via Nemo's thematic baskets. Start from $1.

Author avatar

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

SS&C Technologies (SSNC) Next Earnings Date

SS&C Technologies Holdings (SSNC) is scheduled to report its next earnings on April 23, 2026, based on consensus among financial data providers. This earnings release will cover the first quarter of 2026 (Q1 2026). The company typically announces results after market close and hosts a conference call the same day to discuss quarterly performance and forward guidance. Investors should monitor SS&C's investor relations website for the official announcement and call details as the date approaches.

Which Baskets Do They Appear In?

Healthcare's Efficiency Imperative

Healthcare's Efficiency Imperative

UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.

Published: July 30, 2025

Explore Basket
High-Switching-Cost Traps

High-Switching-Cost Traps

These companies provide solutions that become so essential to their customers' operations that leaving is practically impossible. Professional analysts have selected these stocks for their ability to generate reliable revenue thanks to the immense difficulty and expense customers face when considering alternatives.

Published: June 17, 2025

Explore Basket

Buy SSNC or GWRE in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

SS&C TechnologiesTyler Technologies

SS&C Technologies vs Tyler Technologies

SS&C Technologies vs Tyler Technologies: a neutral, side-by-side comparison of business models, financial metrics, and market context to aid research.

SS&C Technologiesonsemi

SS&C Technologies vs onsemi

A neutral, educational comparison of SS&C Technologies and onsemi, analysing business models, financials and market context for informed research.

SS&C TechnologiesTwilio

SS&C Technologies vs Twilio

A neutral SS&C Technologies vs Twilio stock comparison covering business models, financial metrics, growth drivers and market context to support informed research.

Frequently asked questions